Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2767_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
25 Мб
Скачать
6 Searching forand selecting studies
https://t.me/medicina_free
6.4.6 Identifying fraudulent studies, other retracted publications, errata andcomments
It is important to check at the initial search stage– before data extraction– whether eligi­ble studies have been corrected or retracted, and also at the review update stageforany retractions or corrections since initial publication. Reports of retracted studies in MEDLINE are assigned the Publication Type ‘Retracted Publication’. However, journal editors do not always retract studies that warrant this sanction (Elia 2014) ordonot do so promptly, so corrections, errata, comments and expressions of concern should also be examined. Another source to identify retractions is Retraction Watch (www.retractionwatch.com) and the related Retraction Watch Database (www.retractiondatabase.org). Some refer­ence management software links with the Retraction Watch database and sends an auto­matic notification when the reference to a study matches a retraction in the database. Information on how to search for retracted publications, errata and expressions of con­cern can be found in the online technical supplement of the Cochrane Handbook for Systematic Reviews of Interventions, Section3.9 (Lefebvre 2021).
Identifying fraudulent studies is challenging (Boughton 2021). For guidance, consult the Cochrane Policy for Managing Potentially Problematic Studies (www.cochranelibrary. com/cdsr/editorial-policies#problematic-studies) and the accompanying
implementation guidance (documentation.cochrane.org/display/EPPR/Policy+for+managing+potentia lly+problematic+studies%3A+implementation+guidance).
6.4.7 Minimizing therisk ofbias through search methods
Systematic reviews are distinct from traditional narrative reviews. Systematic reviews set out to identify as many relevant studies as possible and document searches in a transparent way and with sufficient detail to be reproduced. These features help to minimize bias and increase the reliability of review findings (Easterbrook 1991, Egger 1998, Song 2000, Dickersin2005).
Bias resulting from the search process could arise when studies with certain results (often the more positive results) are easier to find than others and the search strategy has not sufficiently accounted for this phenomenon. However, most of the evidence for possible bias comes from work on systematic reviews of the effectiveness of interven­tions, and it is not yet clear whether publication and reporting biases exist in the same way for test accuracy studies. There is evidence of test accuracy studies failing to achieve full publication (Brazzelli 2009, van Enst 2015, Korevaar 2016) or being subject to selec­tive reporting (Rifai 2008). Higher accuracy has been shown to be associated with faster publication of diagnostic imaging studies (van Enst 2015, Cherpak 2019, Treanor 2021). However, whether there is a general relationship between study results, study size and time to publication is uncertain. Language bias and bias in the reporting of certain sub­groups or results within test accuracy publications require further research.
The risk of introducing bias from the search can be minimized by searching several electronic databases and using additional methods to retrieve published and unpub­lished studies (Whiting 2008). A search of MEDLINE alone is generally not considered adequate for systematic reviews and may lead to bias (van Enst 2014). Even if relevant records are in MEDLINE, it can be difficult to retrieve them efficiently; by extending the search to other sources, some of these records may be retrieved elsewhere (Golder
114
6.5 Documenting andreporting thesearch process
https://t.me/medicina_free
2006, Whiting 2008). For intervention reviews, searching Embase in addition to MEDLINE has been shown to affect the estimate of effectiveness (Sampson 2003), probably partly due to its broader coverage of languages other than English. Evidence about the impact of restricting a search to MEDLINE alone on sensitivity and specificity estimates in syn­theses of test accuracy is sparse (van Enst 2014). Some analyses have suggested that searching MEDLINE alone (van Enst 2014, Rice 2016) or MEDLINE and Embase, together with reference checking (Preston 2015), may be sufficient for systematic reviews of test accuracy. These findings, however, may not be representative, as they are based on small, selected or exploratory convenience samples; have had to rely on known sets of test accuracy studies, where the search strategies of the original meta- analyses were
test accuracy search filters, which may have reduced their sensitivity.
Some studies may be recorded in specialist databases instead of in MEDLINE, for example according to topic (such as the Cumulative Index to Nursing and Allied Health Literature, CINAHL) or geographical area (such as the Latin American and Caribbean Health Sciences Literature, LILACS) (Pereira 2019). There is some evidence to suggest that other databases that might yield additional studies for systematic reviews of test accuracy include the Science Citation Index, BIOSIS and LILACS (Whiting 2008), Scopus, PsycINFO and Embase (Rice 2016). Relying exclusively on a MEDLINE search may retrieve a set of reports unrepresentative of those that would have been identified through a more extensive search of additional sources (Rice 2016).
Supplementary search methods, beyond database searches, include checking refer­ence lists (Greenhalgh 2005, Horsley 2011), forward citation searches, co­sis (Janssens 2015, Belter 2016, Belter 2017, Janssens 2020), handsearching and contacting experts, other research groups and test manufacturers. Additional approaches are needed to detect unpublished test accuracy studies. Although they are not generally required to be recorded in trial registries such as ClinicalTrials.gov and are less often registered than other study types (Korevaar 2014a), prospective registration of test accu­racy studies in existing public registries has been encouraged and a minimal data set has been suggested of the key information needed to describe test accuracy studies within registries, including study type, index test(s) and target condition (Korevaar 2017). Consistently populating these specific data fields for test accuracy studies would also help make the records more discoverable. Searching trial registries for test accuracy studies may therefore prove helpful (Glanville 2021), as may checking for test accuracy study protocols (Zarei 2018). Conference abstracts may also point review authors to ongoing or completed but (as yet) unpublished studies (Cherpak 2019, Korevaar 2020).
citation analy-
6.5 Documenting andreporting thesearch process
It is crucial to document and report the search process clearly, with enough detail to indicate how extensive the search strategy is, which in turn can be a marker of how methodologically sound the review’s evidence base is likely to be. Thorough documen­tation and transparent reporting can also aid in the reproducibility of the search strat­egy and facilitate future updates of the review, as well as provide a resource of potentially useful search terms and their combinations for other researchers of similar reviews to consider.
115
6 Searching forand selecting studies
https://t.me/medicina_free
Consensus has been reached on a minimum set of items to report when document­ing the search process in systematic reviews (PRISMA- S), including specific guidance for reviews of diagnostic test accuracy (PRISMA- DTA and PRISMA- DTA for Abstracts). PRISMA for Searching (PRISMA- S) (Rethlefsen 2021) is an extension to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta- Analyses) Statement, and specifically addresses the reporting of search strategies in systematic reviews. PRISMA- S can be used in conjunction with the PRISMA Statement for Diagnostic Test Accuracy, PRISMA- DTA (McInnes 2018), and its accompanying explanation and elabo­ration article (Salameh 2020), as well as the corresponding checklist, explanation and elaboration PRISMA article for journal and conference abstracts, PRISMA- DTA for Abstracts (Cohen 2021).
Incomplete reporting of the search process in systematic reviews has been noted (Sampson 2008, Roundtree 2009, Niederstadt 2010), including in reviews of test accu­racy (Salameh 2019), and can undermine confidence in the research itself. A study measuring the completeness of reporting of 100 systematic reviews of test accuracy against the PRISMA-
DTA reporting checklist found there was a need for improvement. The sources searched were reported by 87 of the 100 reviews analysed, the last date the search was run by 33 of 100 and the complete search strategies by 42 of 100 (Salameh
2019). In the same study, measuring against the PRISMA- DTA for Abstracts checklist, improvements were also found to be needed, for example in reporting the databases searched (63 of 100) and the last date the search was run (42 of 100).
6.5.1 Documenting thesearch process
Documenting the search process involves keeping a careful record of each step taken by the searcher and will help make the final reporting of the search in the review much easier and less likely to be incomplete. This internal record- keeping of the search pro­cess includes documenting all sources searched, on which date, search terms used, the full strategies as they were run, the yield for each source, details about contacting experts or test manufacturers, searching reference lists, scanning websites and search iterations. Careful documentation is especially important for systematic reviews of test accuracy as methods are still being refined. Searches that are carefully documented can be more easily reported, while good reporting will provide future insight into the best sources of studies and the effects of search strategies on likely sources of bias.
6.5.2 Reporting thesearch process
6.5.2.1 Reporting thesearch process inthe protocol
Any protocol of a systematic review of test accuracy submitted for publication should report the intended search strategy, ideally for each electronic database but at least for one major bibliographic database. Protocols for Cochrane Reviews of diagnostic test accuracy are formally peer reviewed before they are published and before the actual review process starts. Peer reviewing the search strategy at this early stage by informa­tion specialists with expertise in searching for reviews of test accuracy is very impor­tant, as it is the starting point for retrieving the evidence included in the review. Authors of Cochrane Reviews of diagnostic test accuracy are therefore advised to report the complete search strategy in the protocol of at least one database, including the verba­tim search strings so that these can be peer reviewed. Any later changes to the search
116
6.5 Documenting andreporting thesearch process
https://t.me/medicina_free
strategy, and additional search strategies for additional databases, should be described in the final review.
6.5.2.2 Reporting thesearch process inthe review
In the final review report, the searches for systematic reviews should be reported in the review abstract, methods and results sections, with relevant detail provided as supple­mentary appendices. Again, this enables peer review of the search strategy, which is an important quality check for the review as a whole.
The PRISMA for Diagnostic Test Accuracy Statement (PRISMA- DTA) should be followed (McInnes 2018). PRISMA- DTA provides a 27- point checklist including recommendations for reporting of four items relating to searching, covering (1) what should be reported in the abstract by referring to PRISMA-
DTA for Abstracts (Cohen 2021); (2) all information sources used (their coverage and dates last searched); (3) full search strategies for each source searched (any limits); and (4) study selection, ideally presented as a flow dia­gram through the search process. The PRISMA- DTA for Abstracts recommends that keydatabases and the dates when each was last searched be included in the search methods section of an abstract (Cohen 2021). Review authors may also wish to refer tothe PRISMA extension for searching that covers reporting of literature searches in systematic reviews of all types (PRISMA- S) (Rethlefsen 2021).
Full search strategies (preferably copied and pasted from the original saved search strategies rather than retyped) should be included as an appendix to the review. All other resources used should also be reported, including grey literature resources, hand­searching, online searches, citation tracking (forward and backward citation searching and co- citation searches) and any contact with study authors, experts or commercial organizations, such as test manufacturers. Complex searches, such as the use of multi­stranded approaches in searching for test accuracy studies, should be explained in a narrative way so that the logic of their construction is clear and so that they can be understood and replicated (Cooper 2018).
The dates on which the searches were done may be different from the dates until which the searches were done. For example, review authors may restrict searches to complete years (e.g. until 1January 2021) instead of to the actual date of the search (e.g. conducted on 3March 2021). Both dates should be reported in the review. The starting year for the search should also be reported, especially if the database was not searched from its inception date onwards (e.g. the starting date is dictated by the avail­ability of the index test). Reporting the relevant dates of the search strategy and the search conduct enables readers and peer reviewers to assess how relevant the current review may be. Although guidelines for search dates may differ between tests and target conditions (a test that evolves rapidly may need a more up- to- date search than a test that remains stable for decades), a rule of thumb is for searches to have been conducted within the 12months before publication of the review.
The results section of the review should include a comprehensive summary of the result of the search, including the total number of citations identified and the number of records remaining after deduplication; the number of records included after title andabstract screening; and the number of reports that were finally included in the review after full text assessment. The PRISMA Statement recommends reporting the flow of citations through the systematic review process in a flow diagram (see Figure 6.5.a). PRISMA 2020 flow diagram templates for both new reviews and
117
*Consider, if feasible to do so, reporting the number of records identified from each database or register searched (rather tha **If automation tools were used, indicate how many records were excluded by a human and how many were excluded by automation tools.
Identification of studies via databases and registers
https://t.me/medicina_free
Records identified from*:
Databases (n =) Registers (n =)
Recordsremoved before screening:
Duplicate records removed (n = ) Records marked as ineligible by automation tools (n = ) Records removed for other reasons (n = )
Identification of studiesv ia other methods
Recordsidentified from:
Websites (n = ) Organisations (n = ) Citation searching (n = ) etc.
Records screened (n = )
Reports sought for retrieval (n = )
Reports assessed for eligibility (n = )
Studies included in review (n = ) Reports of included studies (n = )
Included Screening Identification
Records excluded** (n = )
Reports not retrieved (n =)
Reportsexcluded:
Reason 1 (n = ) Reason 2 (n = ) Reason 3 (n = ) etc.
Reports sought for retrieval (n = )
Reports assessed for eligibility (n = )
n the total number across all databases/registers).
Reports not retrieved (n = )
Reportsexcluded:
Reason 1 (n = ) Reason 2 (n = ) Reason 3 (n = ) etc.
Figure6.5.a The PRISMA 2020 flow diagram for new systematic reviews that included searches of databases and registers only
6.6 Selecting relevant studies
https://t.me/medicina_free
review updates can be downloaded from the PRISMA Statement website (www.prisma­statement.org) andedited to suit. Flow diagrams can also be generated using a Shiny App (www.eshackathon.org/software/PRISMA2020.html).
6.6 Selecting relevant studies
Once initial searches of bibliographic databases have been completed, the next stage of the selection process, manual judgement for relevancy, can begin. In parallel, searching of additional resources (e.g. handsearching, web searching or finding grey literature) can continue, as this may take longer. Ongoing studies identified by the searches may be completed during the course of the review, so can be judged later on during the review process. Checking reference lists of included studies can only start after these studies have been identified.
Starting with the bibliographic database searches, all search results should be merged using reference management software and duplicate records of the same study report removed, so that one set of initially retrieved unique records can be defined. Reference management software, such as EndNote (www.endnote.com), Mendeley (www. mendeley.com), RefWorks (www.proquest.com/products­Zotero (www.zotero.org), use different algorithms for automated detection of duplicate records, and open- source software programs have been developed for this purpose (Jiang 2014, Rathbone 2015). No consensus has been reached on the optimal process for deduplication and a combination of automated methods and visual inspection is common. For a list of selected reference management software, see Section4.1 of the online technical supplement of the Cochrane Handbook for Systematic Reviews of Interventions (Lefebvre 2021). For more detail on methods for removing duplicates using reference management software or the use of open- source software programs, see Section4.3 of the online technical supplement (Lefebvre 2021).
The initial screening phase is based on an examination of titles and abstracts. In this phase, obviously irrelevant records should be removed, for example reports about com-
services/refworks.html) and
than an accuracy question. Reviews, overviews and editorials should also be removed but, where relevant to the review question, may be flagged for checking the reference lists. It is important to be aware that titles and abstracts are not always good reflections of the study described in the full report. It is therefore not advisable at this stage in the process to exclude records because eligible index test(s) are not mentioned in the title or abstract. Some studies may have compared multiple index tests, but reported only one in the abstract.
Screening of titles and abstracts can be done in reference management software, in online software applications specifically designed for literature reviews or in spreadsheet software such as Excel. The benefit of online software applications is that deduplicated search results can be uploaded and screened online and reports that pass the first stage (title and abstract screening) are automatically forwarded to the next stage (full- text screening). Some applications allow lists of relevant or irrelevant keywords to be added and their appearance highlighted on each record to aid screening decisions, while others sort the order of screening based on the potential relevance of the record using machine learning algorithms. More information about these techniques and about further
119
6 Searching forand selecting studies
https://t.me/medicina_free
automation of the selection process through machine learning and text mining can be found in Section4.6.6 of the Cochrane Handbook for Systematic Reviews of Interventions.
Although title and abstract screening can be carried out by one review author alone– especially when this author is over- inclusive – it is recommended that at least two review authors examine every title and abstract independently from each other. This way errors can be minimized and bias from subjective exclusions reduced.
Review authors who are used to screening for intervention reviews may be surprised, first by the initial number of records to be screened for a review of test accuracy, and subsequently by the number of reports remaining for full- text assessment. The frequent complexity of searches for test accuracy studies (see Section6.4) can lead to retrieval of large numbers of records. The variety of study designs that may be used to evaluate the accuracy of tests (see Chapter3) makes it difficult to define preferred designs to help narrow study selection. Authors of diagnostic accuracy reviews should expect a rela­tively high workload in the screening and selection process (Petersen 2014).
6.6.1 Examine full- text reports forcompliance ofstudies witheligibility criteria
After the first round of selection based on title and abstract, the next phase is to exam­ine full- text reports to identify studies that meet the review eligibility criteria. In this phase the decision will be made to either include or exclude records, therefore every record should be assessed by two review authors independently from each other. Apre­specified list of reasons for exclusion should be used and at least one explicit reason for exclusion should be documented for every excluded study. Disagreements may be solved by discussion, or by a third person or ‘arbiter’.
The information that is needed to assess study eligibility is often not available in the abstract and may sometimes be ‘hidden’, or not explicitly stated, even in the full text of the study report. For example, studies do not always report what reference standard was used to define the presence of the target condition or provide key details about how it was applied in the study. In these situations, review authors have to make judge­ment calls about study inclusion, e.g. if the reference standard (or other key aspect of the study) is not clear, will studies be included or not? Ideally, potentially difficult deci­sions like this should be addressed a priori in the review eligibility criteria; however, it is not possible to anticipate every nuance in advance and independent screening of every
text report helps ensure consistency in decision- making.
full-
Although time consuming, correspondence with investigators of potentially relevant studies, for example to ask whether the correct reference standard was used or to clar­ify other aspects of study eligibility, can be very fruitful and help ensure all relevant studies are included (see Chapter7, Section7.2.2).
During this phase, review authors may also encounter multiple reports of the same study, or multiple studies in one study report (see also Chapter7, Section7.2.1). As the studies, and not the reports, are the unit of analysis in a systematic review, it is impor­tant to find out whether multiple reports from the same studies have been published and to link together multiple reports of the same study. It is possible, for example, that a study was designed as a comparative study, but that the data for each test were reported in a separate publication.
Studies are often excluded because complete 2×2 tables could not be derived. However, if the study meets all the other eligibility criteria for a review, then it may be
120
6.8 Chapter information
https://t.me/medicina_free
important to flag how many studies could have been summarized but did not provide the required data.
6.7 Future developments inliterature searching andselection
One problem in searching for and selecting test accuracy studies is the lack of relevant index terms to capture the study design in some bibliographic databases. Another problem is that relevant information may be reported in various study designs (see Chapter3). In the long term it is hoped that there will be a mechanism for re- tagging test accuracy studies in MEDLINE with a specific suitable Publication Type (similar to the way in which randomized controlled trials are now labelled) to facilitate searching. Such a term, ‘diagnostic test accuracy study’, was introduced in Embase in 2011 (Cochrane Community2011) as a check tag, a designated term for indexers to use to denote study types. However, ‘diagnostic test accuracy study’ retrieves only about half of the test accuracy studies in Embase (Gurung 2020) published since 2011, and obvi­ously none before that date.
More promising developments include crowdsourcing and solutions involving the use of artificial intelligence, such as machine learning. Searching for thousands of test accu­racy studies using a very broad and sensitive search is one thing, but these records need to be screened for relevance as well. Cochrane is exploring innovative methods includ­ing crowdsourcing techniques (where many volunteers contribute their time to screen records) to assist in the screening of otherwise unmanageable numbers of records and to minimize the risk of missing relevant studies. So far, crowd screening has been mainly used to identify randomized controlled trials (Noel­screening approach could be developed to identify studies for systematic reviews of diagnostic test accuracy and generate a sufficiently large data set from which to develop a test accuracy study classifier, similar to the Cochrane RCT Classifier (Thomas 2021) and the recently validated Cochrane COVID- 19 Study Classifier, using machine learning techniques (Shemilt 2022). New techniques, including text mining or deep learning methods, have applications for search strategy design, for screening the results for sys­tematic reviews and for data extraction and quality assessment. Research has shown that these approaches may improve the efficiency and accuracy of these tasks (Marshall 2019, Norman 2019). These approaches may be especially helpful for review updates, although the final performance of the technique chosen strongly depends on careful data preparation (data pre- processing) (Lange 2021). These are fast- moving areas of research and development, and review authors are advised to keep an eye on such techniques and approaches, to be able to take advantage of developments as they become available.
Storr 2021), but it is hoped that this
6.8 Chapter information
Authors: René Spijker (Cochrane Netherlands, Utrecht University; Medical Library, University of Amsterdam, The Netherlands), Jacqueline Dinnes (Institute of Applied Health Research, University of Birmingham, UK), Julie Glanville (glanville.info, York, UK),
Anne Eisinga (Cochrane UK, Oxford, UK).
121
6 Searching forand selecting studies
https://t.me/medicina_free
Sources of support: Jacqueline Dinnes is supported by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. No other authors declare sources of support for writing this chapter.
Declarations of interest: René Spijker is an Information Specialist with Cochrane Netherlands. Jacqueline Dinnes is a member of Cochrane’s Diagnostic Test Accuracy Editorial Team. Julie Glanville was a co- convenor of the Cochrane Information Retrieval Methods Group at the time of writing the chapter, and is co- producer of several web­sites and resources mentioned in the chapter: ISSG Search Filters Resource, SuRe Info and a Clinical Trials Registers resource. Anne Eisinga is an Information Specialist with Cochrane UK. The authors declare no other potential conflicts of interest relevant to the topic of their chapter.
Acknowledgements: This chapter re-
uses and builds on material included in the follow­ing chapters of the Cochrane Handbook for Systematic Reviews of Interventions to ensure consistency in guidance for authors of Cochrane Reviews: (1) Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M- I, Noel- Storr A, Rader T, Shokraneh F, Thomas J, Wieland LS. Chapter4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane,
2021. (2) Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M- I, Noel- Storr A, Rader T, Shokraneh F, Thomas J, Wieland LS. Technical supplement to Chapter4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. We are grateful to the authors for kindly sharing pre- publication drafts with us.
The authors thank Lotty Hooft, Madhukar Pai, Yngve Falck- Ytter, Lucas Bachmann, Fritz Grossenbacher, Mark Bruyneel, Ruth Mitchell, Henrica CW de Vet, Ingrid I Riphagen, Bert Aertgeerts, Daniel Pewsner and the many information specialists for contributions to a previous version of this chapter.
The authors would like to thank April Coombe, Anna Noel-
Storr and the Cochrane
Information Specialist Executive for helpful peer review comments.
6.9 References
Bachmann LM, Coray R, Estermann P, Ter Riet G. Identifying diagnostic studies in MEDLINE:
reducing the number needed to read. Journal of the American Medical Informatics Association 2002; 9: 653–658.
Bayliss S, Davenport C. Locating systematic reviews of diagnostic studies: how five
specialist review databases measure up [abstract]. Fourth Annual Meeting of Health Technology Assessment International (HTAi); 2007 Jun 17- 20; Barcelona, Catalonia, Spain.
Belter CW. Citation analysis as a literature search method for systematic reviews. Journal of
the Association for Information Science and Technology 2016; 67: 2766–2777.
122
6.9 References
https://t.me/medicina_free
Belter CW. A relevance ranking method for citation- based search results. Scientometrics
2017; 112: 731–746.
Beynon R, Leeflang MM, McDonald S, Eisinga A, Mitchell RL, Whiting P, Glanville JM. Search
strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE. Cochrane Database of Systematic Reviews 2013; 9: MR000022.
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, Lijmer JG, Moher D,
Rennie D, de Vet HC, Kressel HY, Rifai N, Golub RM, Altman DG, Hooft L, Korevaar DA, Cohen JF. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015; 351: h5527.
Boughton SL, Wilkinson J, Bero L. When beauty is but skin deep: dealing with problematic
studies in systematic reviews. Cochrane Database of Systematic Reviews 2021; 6:ED000152.
Bramer WM, Rethlefsen ML, Kleijnen J, Franco OH. Optimal database combinations for
literature searches in systematic reviews: a prospective exploratory study. Systematic Reviews 2017; 6: 245.
Brazzelli M, Lewis SC, Deeks JJ, Sandercock PA. No evidence of bias in the process of
publication of diagnostic accuracy studies in stroke submitted as abstracts. Journal of Clinical Epidemiology 2009; 62: 425–430.
Briscoe S. Web searching for systematic reviews: a case study of reporting standards in the
UK Health Technology Assessment programme. BMC Research Notes 2015; 8: 153.
Cherpak LA, Korevaar DA, McGrath TA, Dang W, Walker D, Salameh J-
P, Dehmoobad Sharifabadi A, McInnes MDF. Publication bias: association of diagnostic accuracy in radiology conference abstracts with full-
text publication. Radiology 2019; 292:
120–126.
Cochrane Community. EMBASE introduces diagnostic test accuracy study as an indexing
term 2011. community.cochrane.org/news/ embase-
introduces- diagnostic- test- accuracy- study- indexing- term.
Cohen JF, Korevaar DA, Wang J, Spijker R, Bossuyt PM. Should we search Chinese biomedical
databases when performing systematic reviews? Systematic Reviews 2015; 4: 23.
Cohen JF, Korevaar DA, Gatsonis CA, Glasziou PP, Hooft L, Moher D, Reitsma JB, de Vet HC,
Bossuyt PM. STARD for Abstracts: essential items for reporting diagnostic accuracy studies in journal or conference abstracts. BMJ 2017; 358: j3751.
Cohen JF, Korevaar DA, Bossuyt PM. Diagnostic accuracy studies need more informative
abstracts. European Journal of Clinical Microbiology and Infectious Diseases 2019; 38:1383–1385.
Cohen JF, Deeks JJ, Hooft L, Salameh J-
P, Korevaar DA, Gatsonis C, Hopewell S, Hunt HA, Hyde CJ, Leeflang MM, Macaskill P, McGrath TA, Moher D, Reitsma JB, Rutjes AWS, Takwoingi Y, Tonelli M, Whiting P, Willis BH, Thombs B, Bossuyt PM, McInnes MDF. Preferred reporting items for journal and conference abstracts of systematic reviews and
analyses of diagnostic test accuracy studies (PRISMA- DTA for Abstracts): checklist,
meta­explanation, and elaboration. BMJ 2021; 372: n265.
Cooper C, Dawson S, Peters J, Varley- Campbell J, Cockcroft E, Hendon J, Churchill R.
Revisiting the need for a literature search narrative: a brief methodological note. Research Synthesis Methods 2018; 9: 361–365.
Devillé W, Buntinx F. Guidelines for conducting systematic reviews of studies evaluating the
accuracy of diagnostic tests. In:JA Knottnerus, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002a.
123